Interleukin-17 Receptor A Signaling in Transformed Enterocytes Promotes Early Colorectal Tumorigenesis
Open Access
- 1 December 2014
- journal article
- research article
- Published by Elsevier BV in Immunity
- Vol. 41 (6), 1052-1063
- https://doi.org/10.1016/j.immuni.2014.11.009
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Interleukin-11 Is the Dominant IL-6 Family Cytokine during Gastrointestinal Tumorigenesis and Can Be Targeted TherapeuticallyCancer Cell, 2013
- Chemotherapy-triggered cathepsin B release in myeloid-derived suppressor cells activates the Nlrp3 inflammasome and promotes tumor growthNature Medicine, 2012
- IL-10 Elicits IFNγ-Dependent Tumor Immune SurveillanceCancer Cell, 2011
- The profile of Th17 subset in gliomaInternational Immunopharmacology, 2011
- Mutant Kras Promotes Hyperplasia and Alters Differentiation in the Colon Epithelium but Does Not Expand the Presumptive Stem Cell PoolGastroenterology, 2011
- IL-17 Enhances Tumor Development in Carcinogen-Induced Skin CancerCancer Research, 2010
- TH17 cells in tumour immunity and immunotherapyNature Reviews Immunology, 2010
- Ablation of IL-17A abrogates progression of spontaneous intestinal tumorigenesisProceedings of the National Academy of Sciences of the United States of America, 2010
- IL-6 and Stat3 Are Required for Survival of Intestinal Epithelial Cells and Development of Colitis-Associated CancerCancer Cell, 2009
- Requirement of Interleukin 17 Receptor Signaling for Lung Cxc Chemokine and Granulocyte Colony-Stimulating Factor Expression, Neutrophil Recruitment, and Host DefenseThe Journal of Experimental Medicine, 2001